Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Molecular Genetics |
RCV001374896 | SCV001572183 | pathogenic | Neurodevelopmental disorder | 2020-04-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002514854 | SCV003522731 | uncertain significance | not provided | 2022-12-14 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 161196). This missense change has been observed in individual(s) with autosomal dominant spinocerebellar ataxia (PMID: 25070513). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 171 of the TMEM240 protein (p.Arg171Trp). |
OMIM | RCV000148348 | SCV000195812 | pathogenic | Spinocerebellar ataxia type 21 | 2014-10-01 | no assertion criteria provided | literature only |